Literature DB >> 16842165

Imaging of tumor angiogenesis: current approaches and future prospects.

Heike E Daldrup-Link1, Gerhard H Simon, Robert C Brasch.   

Abstract

Tumor angiogenesis imaging should provide non-invasive assays of tumor vascular characteristics to supplement the now conventional diagnostic imaging goals of depicting tumor location, size, and morphology. This article will review the current status of angiogenesis imaging approaches, considering ultrasound, CT, MR, SPECT, PET and optical techniques with attention to their respective capabilities and limitations. As a group, these imaging methods have some potential to depict and quantify tumor microvascular features, including those considered to be functionally associated with tumor angiogenesis. Additionally, new molecule-specific imaging techniques may serve to depict those biochemical pathways and regulatory events that control blood vessel growth and proliferation. Non-invasive monitoring of anti-angiogenic therapies has great appeal and should find wide application for defining tumor microvascular and metabolic changes, because treatment-related changes in tumor morphology tend to occur rather late and are non-specific. Future developments are likely to include "fusion" or "hybrid" imaging methods. Superimposed data from MR imaging with spectroscopy, PET with CT, and PET with MR should be able to integrate advantages of different modalities yielding comprehensive information about tumor structure, function and microenvironment.

Entities:  

Mesh:

Year:  2006        PMID: 16842165     DOI: 10.2174/138161206777698774

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  13 in total

1.  Characterization of carotid artery plaques with USPIO-enhanced MRI: assessment of inflammation and vascularity as in vivo imaging biomarkers for plaque vulnerability.

Authors:  Stephan Metz; Ambros J Beer; Marcus Settles; Jaroslav Pelisek; René M Botnar; Ernst J Rummeny; Peter Heider
Journal:  Int J Cardiovasc Imaging       Date:  2010-10-24       Impact factor: 2.357

2.  Correlation of MRI biomarkers with tumor necrosis in Hras5 tumor xenograft in athymic rats.

Authors:  Daniel P Bradley; Jean J Tessier; Susan E Ashton; John C Waterton; Zena Wilson; Philip L Worthington; Anderson J Ryan
Journal:  Neoplasia       Date:  2007-05       Impact factor: 5.715

3.  MRI of tumor-associated macrophages with clinically applicable iron oxide nanoparticles.

Authors:  Heike E Daldrup-Link; Daniel Golovko; Brian Ruffell; David G Denardo; Rosalinda Castaneda; Celina Ansari; Jianghong Rao; Grigory A Tikhomirov; Michael F Wendland; Claire Corot; Lisa M Coussens
Journal:  Clin Cancer Res       Date:  2011-07-26       Impact factor: 12.531

Review 4.  Non-invasive assessment of vessel morphology and function in tumors by magnetic resonance imaging.

Authors:  Fabian Kiessling; Manfred Jugold; Eva C Woenne; Gunnar Brix
Journal:  Eur Radiol       Date:  2007-02-17       Impact factor: 7.034

5.  Integrin imaging to evaluate treatment response.

Authors:  Matthew Morrison; Alan Cuthbertson
Journal:  Theranostics       Date:  2011-02-11       Impact factor: 11.556

6.  MR imaging of tumor-associated macrophages.

Authors:  Heike Daldrup-Link; Lisa M Coussens
Journal:  Oncoimmunology       Date:  2012-07-01       Impact factor: 8.110

7.  In vivo performance of a liposomal vascular contrast agent for CT and MR-based image guidance applications.

Authors:  Jinzi Zheng; Jubo Liu; Mike Dunne; David A Jaffray; Christine Allen
Journal:  Pharm Res       Date:  2007-03-21       Impact factor: 4.580

8.  Alk5 inhibition increases delivery of macromolecular and protein-bound contrast agents to tumors.

Authors:  Heike E Daldrup-Link; Suchismita Mohanty; Celina Ansari; Olga Lenkov; Aubie Shaw; Ken Ito; Su Hyun Hong; Matthias Hoffmann; Laura Pisani; Nancy Boudreau; Sanjiv Sam Gambhir; Lisa M Coussens
Journal:  JCI Insight       Date:  2016-05-06

Review 9.  How to stop using gadolinium chelates for magnetic resonance imaging: clinical-translational experiences with ferumoxytol.

Authors:  Heike E Daldrup-Link; Ashok J Theruvath; Ali Rashidi; Michael Iv; Robbie G Majzner; Sheri L Spunt; Stuart Goodman; Michael Moseley
Journal:  Pediatr Radiol       Date:  2021-05-27

10.  Imaging Tumor Necrosis with Ferumoxytol.

Authors:  Maryam Aghighi; Daniel Golovko; Celina Ansari; Neyssa M Marina; Laura Pisani; Lonnie Kurlander; Christopher Klenk; Srabani Bhaumik; Michael Wendland; Heike E Daldrup-Link
Journal:  PLoS One       Date:  2015-11-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.